Merus N.V. Gains 32.55%

Fri, May 27, 2022 at 05:30 PM

Merus N.V. (MRUS:NASDAQ) rocketted at $18.53, a gain of 32.5%. On Thu, May 26, 2022, MRUS:NASDAQ touched a New 2-Week Low of $13.98. The stock got featured on our News Catalysts scanner on Thu, May 26, 2022 at 05:10 PM in the 'BIOTECH' category. From Thu, May 12, 2022, the stock recorded 50.00% Up Days and 27.27% Green Days

About Merus N.V. (MRUS:NASDAQ)

Merus BV is a clinical stage immuno-oncology company. It is engaged in developing bispecific antibody therapeutics.

Top 10 Gainers:

Avadel Pharmaceuticals plc (AVDL:NASDAQ), 133.64%
Oncternal Therapeutics, Inc. (ONCT:NASDAQ), 88.08%
Allarity Therapeutics Inc. (ALLR:NASDAQ), 39.32%
Imperial Petroleum Inc. (IMPP:NASDAQ), 38.38%
JE Cleantech Holdings Limited (JCSE:NASDAQ), 34.8%
Merus N.V. (MRUS:NASDAQ), 32.55%
Farfetch Limited (FTCH:NYSE), 26.69%
Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 25.71%
Grom Social Enterprises Inc. (GROM:NASDAQ), 25.48%
Icosavax Inc. (ICVX:NASDAQ), 25.37%